Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Bids Adieu To Allergenic Products Adcomm; Vaccines Panel To Take Over Duties
Jul 26 2024
•
By
Sue Sutter
Responsibility for allergen testing agents and treatments will shift to the FDA's vaccines panel. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA Performance Tracker
More from Regulatory Trackers